Skip to content
SHM Abstracts | Society of Hospital Medicine Logo
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
Search2020-05-20T12:01:36-05:00
Search
Search by Abstract Number, Title, Keyword, or Authors
Category
Sub-Category

(Optional)

Session Type
Meeting
Search Results for irAE
Abstract Number: 477
A CURIOUS CASE OF ATEZOLIZUMAB-ASSOCIATED RHEUMATIC AND MUSCULOSKELETAL ADVERSE EFFECTS
SHM Converge 2023
Case Presentation: A 71-year-old male with a history of diabetes, hyperlipidemia, and stage II small cell bladder cancer on cycle 2 of cisplatin, etoposide, and atezolizumab that he received 1 week ago presented with neck stiffness, pain, fevers, and diffuse muscle aches to his PCP. Concerned about meningitis he was sent to the hospital. A […]
Abstract Number: 636
THE DOUBLE-EDGE SWORD: WHEN PD-1 INHIBITORS TAKE MORE THAN CANCER
SHM Converge 2023
Case Presentation: This case describes a 63-year-old male who was recently diagnosed with renal cell carcinoma with metastasis to the lungs confirmed with a biopsy showing diffuse PAX-8 positivity on an immunohistochemical staining panel favoring renal origin. He was started on Nivolumab/Ipilimumab however was hospitalized in the intensive care unit for septic shock due to […]
Abstract Number: 676
KEEP AN EYE OUT FOR IMMUNE RELATED ADVERSE EVENTS (IRAES)
SHM Converge 2023
Case Presentation: A 78-year-old female with a history of uterine carcinosarcoma diagnosed two years ago presented to the ED with a primary complaint of orbital swelling, blurry vision, and diplopia OS. One week prior, she received her 5th and 1st cycle of Pembrolizumab and Zometa infusion, respectively for her uterine carcinosarcoma. Three days status post, […]
Abstract Number: 837
PLASMA EXCHANGE FOR IMMUNE CHECKPOINT INHIBITOR INDUCED ACUTE DEMYELINATING POLYNEUROPATHY
SHM Converge 2023
Case Presentation: A 69-year-old male with a past medical history of urothelial carcinoma status post left nephrectomy began immunotherapy and was started on Atezolizumab. He developed bilateral lower extremity weakness that began following his first dose. After 3 doses, in 02/2022, his lower extremity weakness worsened to the point where he could not walk. A […]
  • This Week

  • This Month

  • All Time

  • This Week

  • A CASE OF SKIN NECROSIS CAUSED BY INTRAVENOUS XYLAZINE ABUSE
  • A Patient’s Presentation of Persistent Sweet Taste in Her Mouth Leads to a Diagnosis of Small Cell Lung Cancer
  • RECOGNIZING S1Q3T3 FOR WHAT IT IS: A NONSPECIFIC PATTERN OF RIGHT HEART STRAIN
  • Bc Powder Causing Intracerebral Bleed: Pitfalls of Overlooking Dosage of Seemingly Innocuous Otc Formulations
  • When a Stiff Neck Is Not Meningitis
  • This Month

  • A CASE OF SKIN NECROSIS CAUSED BY INTRAVENOUS XYLAZINE ABUSE
  • REMDESIVIR REDUCES MORTALITY IN HOSPITALIZED COVID-19 PATIENTS REQUIRING LOW-FLOW OXYGEN
  • RECOGNIZING S1Q3T3 FOR WHAT IT IS: A NONSPECIFIC PATTERN OF RIGHT HEART STRAIN
  • A Patient’s Presentation of Persistent Sweet Taste in Her Mouth Leads to a Diagnosis of Small Cell Lung Cancer
  • ADDERALL INDUCED ISCHEMIC COLITIS
  • All Time

  • ADDERALL INDUCED ISCHEMIC COLITIS
  • Bc Powder Causing Intracerebral Bleed: Pitfalls of Overlooking Dosage of Seemingly Innocuous Otc Formulations
  • PECULIAR PRESENTATION OF VERTIGO IN HYPOTHYROIDISM
  • A CASE OF SKIN NECROSIS CAUSED BY INTRAVENOUS XYLAZINE ABUSE
  • RECOGNIZING S1Q3T3 FOR WHAT IT IS: A NONSPECIFIC PATTERN OF RIGHT HEART STRAIN
© Society of Hospital Medicine | All Rights Reserved
Page load link
Go to Top